Combining Operational Expertise and Investment Acumen to Transform Healthcare Technology
Kristin Baker Spohn is a prominent healthcare‐tech executive turned venture capitalist, whose career trajectory reflects a unique blend of operational expertise, investment acumen, and strategic leadership. With a strong educational foundation, hands-on startup experience, and a track record of thoughtful venture investing, Spohn has become a leading figure in the healthcare and enterprise technology sectors.
Facts: Kristin Baker Spohn
| Fact | Details |
|---|---|
| Full Name | Kristin Baker Spohn |
| Education | BA – Middlebury College; MBA – Stanford GSB |
| Early Career | Goldman Sachs (healthcare finance); Angel investor, Stanford Life Science Angel Network |
| Startup Roles | Castlight Health (finance & partnerships); Collective Health (Chief Commercial Officer) |
| Venture Capital | Social Capital (early-stage partner); CRV (GP, healthcare & enterprise tech); BAM Elevate (founding GP, growth-stage) |
| Notable Investments | Viz.ai, Waitwhile, Wheel, Modern Health, Little Otter |
| Board Roles | Waitwhile, Wheel, advisory for Modern Health & other portfolio companies |
| Key Focus Areas | Enterprise and healthcare technology, stakeholder alignment, founder support |
| Public Recognition | CRV blogs, founder interviews, HLTH conference talks, media features |
| Philosophy | Align incentives, prioritize strong teams, focus on technical & market fit, advocate for diversity & mentorship |
Early Life and Education
Spohn’s journey into healthcare and technology was shaped early by her academic pursuits. She earned her Bachelor of Arts from Middlebury College, followed by an MBA from Stanford Graduate School of Business. During her time at Stanford, she became involved with the Life Science Angel Network, gaining practical exposure to early-stage investing and deal evaluation in the life sciences sector.
Reflecting on this period, Spohn has mentioned that her engagement in angel investing helped her understand how to “invest [her] own time and energy building and scaling companies,” laying the foundation for her dual focus on operational and financial growth in healthcare startups.
Early Career in Healthcare Finance
After completing her MBA, Spohn began her professional career at Goldman Sachs, where she advised clients in biotech, life sciences, and health IT. This experience not only deepened her financial expertise but also nurtured her passion for the healthcare industry. As she recalls, “I fell in love with these companies,” a statement highlighting her early commitment to understanding the intersection of technology, business, and healthcare.
Her involvement with the Stanford Life Science Angel Network during this period allowed her to further explore early-stage investment opportunities, conduct due diligence, and gain firsthand experience in startup operations.
Startup Leadership in Healthcare
Spohn transitioned from finance into hands-on operational roles in high-profile healthcare startups, bringing her financial and strategic knowledge into action.
1. Castlight Health
At Castlight Health, she played a key role in building business development, finance, and investor relations, contributing to the company’s successful public listing in 2014. Her work helped shape the platform’s partnerships, financial operations, and market strategy, providing critical experience in scaling enterprise health technology companies.
2. Collective Health
Later, Spohn became Chief Commercial Officer at Collective Health, a digital benefits platform. In this role, she oversaw go-to-market strategies, partnerships with major clients including Palantir, SpaceX, and Uber, and multiple funding rounds through Series D. Her leadership at Collective Health highlighted her ability to scale teams, design market strategies, and build enterprise-grade technology solutions from the ground up.
Transition to Venture Capital
After extensive operational experience, Spohn transitioned into venture capital, where she has leveraged her knowledge to identify high-potential startups and guide their growth.
1. Social Capital
She began as an early-stage partner at Social Capital, Chamath Palihapitiya’s investment firm, where she focused on enterprise and healthcare technology startups. Her prior experience as an angel investor provided a strong foundation for evaluating opportunities and mentoring founders.
2. CRV (Charles River Ventures)
In 2019, Spohn joined CRV as a General Partner, leading investments in enterprise and healthcare tech. At CRV, she worked alongside co-leads George Zachary and Dylan Morris, managing a portfolio that included startups at the intersection of technology and healthcare.
One notable investment was Viz ai, a startup using AI imaging to identify strokes. Spohn’s involvement extended from early angel investment to leading CRV’s $50 million Series B round. She emphasized aligning incentives between patients, providers, and payers, a principle she frequently underscores when advising founders in the complex healthcare ecosystem.
3. BAM CornerPoint / BAM Elevate
By 2022-2023, Spohn became a founding General Partner at BAM CornerPoint/BAM Elevate, a growth-stage technology fund under Balyasny Asset Management. This move signaled her continued focus on scaling enterprise technology companies at Series B-D stages, demonstrating her versatility in both early-stage and growth-stage investing.
Investment Philosophy
Spohn’s venture investment strategy is shaped by her operational background and deep healthcare knowledge. She emphasizes:
Stakeholder Alignment: Ensuring products align with the incentives of patients, providers, payers, and other key actors.
Founder-Centric Approach: Prioritizing strong founding teams with vision and execution capabilities.
Technical and Market Fit: Investing in companies that demonstrate both innovative technology and clear product-market alignment.
Her philosophy is evident in her investments in companies like Waitwhile, a cloud-based queue management platform, and Wheel, a virtual telehealth platform. In each case, Spohn joined boards and actively guided strategy, reflecting her hands-on approach to venture capital.
Notable Investments and Board Roles
Spohn’s portfolio demonstrates her focus on transformative healthcare and enterprise technologies:
Waitwhile: Cloud-based queue management platform; Spohn joined the board after a $12M Series A investment in 2021.
Wheel: Telehealth virtual care platform; CRV’s investment in 2019 and her subsequent public interview with CEO Michelle Davey highlighted the company’s rapid growth and market fit.
Modern Health: Digital mental health platform; Spohn participated in its $9M Series A in 2019, emphasizing employer-supported behavioral health.
Little Otter: Pediatric mental health services; CRV invested $22M Series A in 2022, with founders praising Spohn’s guidance and alignment-focused approach.
Beyond investing, she takes board seats in these companies, providing strategic oversight, supporting growth, and fostering founder success.
Conclusion
Kristin Baker Spohn exemplifies the modern healthcare venture capitalist: a professional who has walked the operational floor of startups, advised clients in complex financial landscapes, and now invests with strategic insight and a focus on stakeholder alignment. From her early days at Goldman Sachs to her leadership roles at Castlight Health and Collective Health, and finally to her venture career at Social Capital, CRV, and BAM Elevate, Spohn’s journey highlights the power of combining operational expertise with thoughtful investing.
Her work continues to shape the healthcare technology landscape, supporting startups that advance patient care, streamline enterprise solutions, and drive meaningful innovation. Aspiring entrepreneurs and investors alike can draw inspiration from her career, one built on skill, insight, and a commitment to sustainable growth.
